Portal vein velocity and its dynamics: a potentially useful tool for detecting clinically silent transjugular intrahepatic porto-systemic shunt dysfunction using Doppler ultrasonography

Abstract

Background  Ultrasound (US) surveillance for transjugular intrahepatic portosystemic shunt (TIPS) dysfunction has yet to be standardized, as clear-cut criteria have not been conventionally defined. This study evaluated the role of US-based parameters in detecting hemodynamic TIPS dysfunction (HD).

Methods  We included consecutive patients treated with TIPS. All patients were scheduled within the first six weeks after the procedure for TIPS revision, comprised of a Doppler US exam and invasive hemodynamic reassessment. Clinical TIPS dysfunction (CD) was defined as symptom recurrence, while HD was defined by a portal pressure gradient (PPG)≥12 mmHg. The predictive capabilities of Doppler US for predicting TIPS dysfunction were tested against the hemodynamic gold standard.

Results  86 patients were included. Secondary prophylaxis of variceal bleeding was the main indication for TIPS in 72 patients (83.7%), while 27 (31.4%) had refractory ascites. HD occurred in 37 cases (43%), of which 25 patients (67.5%) had no CD. Patients with HD had a significantly lower portal vein velocity (PVV): 35 (20–45) cm/s vs. 40.5 (35–50) cm/s, p=0.02. Compared to the immediate post-TIPS assessment, the patients without HD had a ΔPVV of 6.08±19.8 cm/s vs. a decrease of − 8.2±20.2 cm/s in HD (p=0.04). Using a cut-off value of 40.5 cm/s, PVV had an AUROC of 0.705 for predicting HD, while the addition of ΔPVV (cut-off 9.5 cm/s) improved the AUROC to 0.78.

Conclusion  Despite adequate symptom control, a considerable percentage of patients have a post-TIPS PPG≥12 mmHg. The dynamic assessment of PVV and its temporal dynamics can reliably predict TIPS dysfunction.

Keywords

shunts - interventional procedures - transjugular intrahepatic porto-systemic shunt - TIPS - Color Doppler ultrasound

• References

• 1 Angeli P, Bernardi M, Villanueva C. et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69: 406-460
• 2 De Franchis R, Vi B. Position Paper Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743-752
• 3 Bureau C, Garcia-Pagan JC, Otal P. et al. Improved Clinical Outcome Using Polytetrafluoroethylene-Coated Stents for TIPS: Results of a Randomized Study. Gastroenterology 2004; 126: 469-475
• 4 Perelló MP, Mur JP, Vives MS. et al. Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft. Diagnostic Interv Radiol 2019; 25: 346-352
• 5 Luo X, Zhao M, Wang X. et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. PLoS One 2019; 14: 1-13
• 6 Klinger C, Riecken B, Müller J. et al. Doppler ultrasound surveillance of TIPS-patency in the era of covered stents – Retrospective analysis of a large single-center cohort. Z Gastroenterol 2018; 56: 1053-1062
• 7 Geeroms B, Laleman W, Laenen A. et al. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results. Eur Radiol 2017; 27: 1795-1803
• 8 Weber CN, Nadolski GJ, White SB. et al. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. J Vasc Interv Radiol 2015; 26: 1257-1265
• 9 Perarnau JM, Le Gouge A, Nicolas C. et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial. J Hepatol 2014; 60: 962-968
• 10 Bureau C, Pagan JCG, Layrargues GP. et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: Long-term results of a randomized multicentre study. Liver Int 2007; 27: 742-747
• 11 de Franchis R, Bosch J, Garcia-Tsao G. et al. Baveno VII – Renewing consensus in portal hypertension. J Hepatol 2022; 76: 959-974
• 12 Abraldes JG, Gilabert R, Turnes J. et al. Utility of color doppler ultrasonography predicting TIPS dysfunction. Am J Gastroenterol 2005; 100: 2696-2701
• 13 Young S, Scanlon P, Sherestha P. et al. Duplex Ultrasound Versus Clinical Surveillance in the Prediction of TIPS Malfunction Placed for Refractory Ascites: Is Ultrasound Surveillance Useful?. Cardiovasc Intervent Radiol 2017; 40: 1861-1865
• 14 Rössle M. Review TIPS: 25 years later. J Hepatol 2013; 59: 1081-1093
• 15 Manatsathit W, Samant H, Panjawatanan P. et al. Performance of ultrasound for detection of transjugular intrahepatic portosystemic shunt dysfunction: a meta-analysis. Abdom Radiol 2019; 44: 2392-2402
• 16 Owen JM, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography. J Clin Imaging Sci 2016; 6: 1-7
• 17 Nicolas C, Le Gouge A, d’Alteroche L. et al. Evaluation of Doppler-ultrasonography in the diagnosis of transjugular intrahepatic portosystemic shunt dysfunction: A prospective study. World J Hepatol 2017; 9: 1125-1132
• 18 Pan JJ, Chen C, Geller B. et al. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents. Clin Radiol 2008; 63: 1142-1148
• 19 De Franchis R. Revising consensus in portal hypertension: Report of the Baveno v consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768
• 20 Moore KP, Wong F, Gines P. et al. The management of ascites in cirrhosis: Report on the consensus conference of The International Ascites Club. Hepatology 2003; 38: 258-266
• 21 Silva-Junior G, Turon F, Baiges A. et al. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension. Gastroenterology 2017; 152: 1358-1365